bromodeoxyuridine has been researched along with Optic Nerve Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coulter, M; Levine, JM; Meyer, RL; Miotke, J; Rodriguez, JP; Takemaru, K | 1 |
| Elsaeidi, F; Goldman, D; Powell, C | 1 |
| Albers, GW; Forno, LS; Hoyt, WF; Shratter, LA | 1 |
3 other study(ies) available for bromodeoxyuridine and Optic Nerve Diseases
| Article | Year |
|---|---|
Abrogation of β-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury.
Topics: Animals; beta Catenin; Bromodeoxyuridine; Central Nervous System Diseases; Cicatrix; Disease Models, Animal; Gene Transfer Techniques; Glial Fibrillary Acidic Protein; In Vitro Techniques; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Regeneration; Oligodendroglia; Optic Nerve Diseases; Receptor, Platelet-Derived Growth Factor alpha; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen | 2014 |
Injury-dependent Müller glia and ganglion cell reprogramming during tissue regeneration requires Apobec2a and Apobec2b.
Topics: Animals; Animals, Genetically Modified; Basic Helix-Loop-Helix Transcription Factors; Bromodeoxyuridine; Cell Death; Cytidine Deaminase; ELAV Proteins; Embryo, Nonmammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Green Fluorescent Proteins; In Situ Nick-End Labeling; In Vitro Techniques; Male; Neurogenesis; Neuroglia; Oligonucleotides; Optic Nerve Diseases; Proliferating Cell Nuclear Antigen; Regeneration; Retina; Retinal Ganglion Cells; RNA, Messenger; Time Factors; Transcription Factors; Zebrafish; Zebrafish Proteins | 2012 |
Treatment response in malignant optic glioma of adulthood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cranial Nerve Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Invasiveness; Optic Nerve Diseases; Procarbazine; Vincristine | 1988 |